Top Blood Gas and Electrolyte Analyzers companies

The 10 key players our Blood Gas and Electrolyte Analyzers report profiles, and other companies free public records show in this market.

Key players in Blood Gas and Electrolyte Analyzers

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Blood Gas and Electrolyte Analyzers

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Blood Gas and Electrolyte Analyzers, from free public records
CompanyWhere public records show them
Novartis AG
Xenios AG
Nihon Kohden Corporation
Spectrocor
Apreo Health, Inc.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Blood Gas and Electrolyte Analyzers

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Novartis AG 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Xenios AG 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Nihon Kohden Corporation 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Spectrocor 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Apreo Health, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Blood Gas and Electrolyte Analyzers reports by place

All 33 places for Blood Gas and Electrolyte Analyzers

Get the full Blood Gas and Electrolyte Analyzers report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.